Ann: Appendix 4C - 30 June 2018, page-2

Whilst the share price doesn't reflect this, the company has made real progress over the last quarter.

Proving low toxicity levels and efficacy on a number of pests, furthering collaborations to explore Flavocide, submitting patents and exploring manufacturing costing are some of the highlights.

Encouraging to read "discussions are now underway with a number of major international agchem corporations with respect to collaboration or partnership agreements for potential commercial applications of both Flavocide and Qcide."

Best of all BGT have only burnt through $450K for the quarter.